Skip to main content
. 2023 Jul 5;35(1):e1. doi: 10.3802/jgo.2024.35.e1

Table 2. Adverse events.

Adverse events NCI-CTCAE 5.0
Grade 1 Grade 2 Grade 3 Grade 4
60 mg/m2 (n=3)
Neutropenia 0 1 0 0
Anemia 0 3 0 0
Thrombocytopenia 1 0 0 0
65 mg/m2 (n=3)
Nausea and vomiting 1 0 0 0
Bloating 1 0 0 0
Anemia 0 2 0 0
70 mg/m2 (n=12)
Nausea and vomiting 2 1 0 0
Inappetence 2 0 0 0
Dizziness 3 0 0 0
Fatigue 4 0 0 0
Bloating 1 0 0 0
Diarrhea 2 0 0 0
Neutropenia 0 2 0 0
Anemia 3 3 1 0
Thrombocytopenia 0 1 0 0
75 mg/m2 (n=12)
Nausea and vomiting 4 0 0 0
Bloating 2 0 0 0
Diarrhea 3 0 0 0
Neutropenia 0 3 0 0
Anemia 3 3 1 0
Thrombocytopenia 1 0 0 1
Hepatic function impairment 0 0 1 0
Hypokalemia 0 2 0 0
Hyponatremia 0 2 0 0